Samson T, Shvartzman P.
Secondary traumatization/trauma among employees in palliative care units–the products of prolonged repeated exposure to suffering and death
2012
Harefuah ;151(11):607-10, 656.
01/11/2012
Hamama-Raz Y., Perry S., Pat-Horenczyk R, Bar-levav R, Stemmer S.
Factors affecting participation in group intervention in patients after adjuvant treatment for early-study breast cancer.
2012
Acta Oncol ;51(2):208-14
01/02/2012
Hamama-Raz Y., Perry S., Pat-Horenczyk R, Bar-levav R, Stemmer S.
01/02/2012
Semionov V, Singer Y, Shvartzman P
Prevalence and management of symptoms during the last month of life
2012
Isr Med Assoc J ;14(2):96-9.
01/02/2012
Semionov V, Singer Y, Shvartzman P
01/02/2012
Ahmedzai SH, Nauck F, Bar-Sela G, Bosse B, Leyendecker P, Hopp M.
A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.
2012
Palliat Med 2012;26:50-60.
01/01/2012
Ahmedzai SH, Nauck F, Bar-Sela G, Bosse B, Leyendecker P, Hopp M.
01/01/2012
Bar-Sela G, Lulav-Grinwald D, Mitnik I.
“Balint group” meetings for Oncology residents as a tool to improve therapeutic communication skills and reduce burnout level.
2012
J Cancer Educ 2012;27:786-9.
01/01/2012
Bar-Sela G, Lulav-Grinwald D, Mitnik I.
01/01/2012
Schultz M, Baddarni K, Bar-Sela G.
Reflections on palliative care from the Jewish and Islamic Traditions.
2012
Evid Based Complem Alternat Med 2012;
01/01/2012
Schultz M, Baddarni K, Bar-Sela G.
01/01/2012
Avisar A, River Y, Schiff E, Bar-Sela G, Steiner M, Ben-Arye E.
Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature.
2012
Breast Cancer Res Treat 2012;136:1-7.
01/01/2012
Avisar A, River Y, Schiff E, Bar-Sela G, Steiner M, Ben-Arye E.
01/01/2012
Bar-Sela G, Rimmon A, Berkovich L, Lev-Ari S.
Curcumin: a promise of a native chemoprevention agent that needs to be fulfilled in clinical trials.
2012
Int J Cancer Res Prev 2012;4:369-81.
01/01/2012
Bar-Sela G, Rimmon A, Berkovich L, Lev-Ari S.
01/01/2012
